CPIG
WVE icon

Chicago Partners Investment Group’s Wave Life Sciences WVE Stock Holding History

Chicago Partners Investment Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124K Buy
+16,783
New +$219K ﹤0.01% 1379
2025
Q4 		– Sell
-10,572
Closed -$80.2K – 1342
2025
Q3 		$80.2K Sell
10,572
-1,693
-14% -$13.7K ﹤0.01% 1194
2025
Q2 		$105K Sell
12,265
-443
-3% -$2.92K ﹤0.01% 1065
2025
Q1 		$82.5K Buy
+12,708
New +$139K ﹤0.01% 905
2024
Q2 		– Sell
-18,559
Closed -$94.3K – 774
2024
Q1 		$94.3K Buy
18,559
+7,256
+64% +$36.3K ﹤0.01% 716
2023
Q4 		$49.7K Buy
11,303
+167
+1% +$893 ﹤0.01% 686
2023
Q3 		$59.9K Sell
11,136
-7,663
-41% -$35K ﹤0.01% 638
2023
Q2 		$82.2K Sell
18,799
-9,369
-33% -$37.8K ﹤0.01% 662
2023
Q1 		$113K Buy
28,168
+5,797
+26% +$26.6K 0.01% 641
2022
Q4 		$118K Sell
22,371
-638
-3% -$2.94K 0.01% 613
2022
Q3 		$101K Buy
+23,009
New +$76.2K 0.01% 563
2022
Q1 		– Sell
-11,273
Closed -$28K – 608
2021
Q4 		$28K Sell
11,273
-413
-4% -$1.72K ﹤0.01% 564
2021
Q3 		$55K Buy
+11,686
New +$70.8K ﹤0.01% 575
2021
Q2 		– Sell
-10,830
Closed -$68K – 561
2021
Q1 		$68K Buy
10,830
+454
+4% +$4.36K 0.01% 515
2020
Q4 		$103K Buy
+10,376
New +$87.1K 0.01% 455

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Chicago Partners Investment Group's WVE Position: Q1 2026 in Review

Chicago Partners Investment Group opened a new position in Wave Life Sciences (WVE) in Q1 2026: 16,783 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #1379 among its holdings. This is a return to the name: Chicago Partners Investment Group previously reported a position in WVE as recently as Q3 2025.

Chicago Partners Investment Group first reported a position in WVE in Q4 2020 and has held it in 15 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Chicago Partners Investment Group held 16,783 shares of Wave Life Sciences worth $124K as of Q1 2026.
  • Wave Life Sciences was a new Chicago Partners Investment Group position in Q1 2026.
  • Wave Life Sciences made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q1 2026, its #1379 holding.
  • Chicago Partners Investment Group first reported a position in Wave Life Sciences in Q4 2020 and has held it in 15 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.